EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

The Spectrum of Epidermolysis Bullosa in KwaZulu‐Natal, South Africa

Antoinette Chateau iD, Thirona Naicker iD, Cassandra Bruce-Brand iD, Johann Schneider iD, Colleen Aldous iD, Ncoza Dlova iD, Hui-Ching Cheng iD, Pei-Chi Lin iD, Hsin-Yu Huang iD, Chao-Kai Hsu iD, John A McGrath iD

International Journal of Dermatology · 2025-08 · 64 (8) · 1425-1433

DOI: 10.1111/ijd.17843 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Dermatology, online erschienen am 14.05.2025. Verfasst von Antoinette Chateau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Grey's Hospital, Pietermaritzburg, University of KwaZulu-Natal, School of Clinical Medicine, Durban, South Africa. Hauptthemen laut MEDLINE: Epidermolysis Bullosa, Epidermolysis Bullosa, Junctional. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: College of Health Sciences, University of KwaZulu-Natal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epidermolysis bullosa (EB) is a rare, heterogeneous genodermatosis characterized by skin fragility due to inherited defects in genes encoding proteins that maintain epidermal–dermal integrity. The severity and complications of EB vary by subtype, and no cure currently exists. The epidemiology is unknown in South Africa.

Methods

This prospective observational study in KwaZulu‐Natal correlated African Zulu EB patients' phenotypic features with genotypic and histological findings. Whole‐exome sequencing, electron microscopy, and immunofluorescence mapping were used to identify EB subtypes.

Results

Fourteen of the 15 patients recruited initially were confirmed to have EB, while one was excluded due to poor clinicopathological‐genetic correlation. Junctional EB (JEB) was identified in 11 patients, with 10 cases linked to a recurrent homozygous pathogenic variant in LAMB3 , causing severe JEB, and one to ITGA3 with an unusual variant of interstitial lung disease, nephrotic syndrome, and EB (ILNEB). Two patients had autosomal dominant EB simplex, both with heterozygous KRT14 variants, and one had dominant dystrophic EB associated with a heterozygous COL7A1 variant. Eleven patients presented during the neonatal period, with a mean survival of four weeks, highlighting a high mortality rate, especially in the severe JEB cases. The cohort exhibited a balanced sex distribution, with no clear cases of consanguinity observed.

Conclusion

JEB, with a recurrent pathogenic variant in LAMB3 , emerged as the predominant subtype among African Zulu patients, underscoring the critical need for early diagnosis and tailored management strategies in resource‐limited settings. Integrating clinicopathological and genetic data is essential for accurate diagnosis and prognosis, emphasizing the importance of advanced diagnostic tools in improving outcomes for EB patients in South Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis BullosaEpidermolysis Bullosa, JunctionalHumansSouth AfricaMaleFemaleProspective StudiesInfantChild, PreschoolKalininExome SequencingChildCell Adhesion MoleculesCollagen Type VIIKeratin-14Infant, NewbornSkinPhenotypeAdolescentAdult

Stichwörter der Autor:innen

South AfricaZulu African patientselectron microscopyepidermolysis bullosaimmunofluorescence mappingskin of colorwhole‐exome sequencing

Substanzen

KalininCOL7A1 protein, humanCell Adhesion MoleculesCollagen Type VIIKeratin-14

Autor:innen und Institutionen

  • Department of Dermatology, Grey's Hospital, Pietermaritzburg, University of KwaZulu-Natal, School of Clinical Medicine, Durban, South Africa.
  • Department of Dermatology, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Department of Paediatrics, Medical Genetics, School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Division of Anatomical Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa.
  • JDW Pathology, Cape Town, South Africa.

ORCID-Profile: Antoinette Chateau, Thirona Naicker, Cassandra Bruce-Brand, Johann Schneider, Colleen Aldous, Ncoza Dlova, Hui-Ching Cheng, Pei-Chi Lin, Hsin-Yu Huang, Chao-Kai Hsu, John A McGrath

Förderung

  • College of Health Sciences, University of KwaZulu-Natal

Zitieren

APA

Chateau, A., Naicker, T., Bruce-Brand, C., Schneider, J., Aldous, C., Dlova, N., Cheng, H. C., Lin, P. C., Huang, H. Y., Hsu, C. K., & McGrath, J. A. (2025). The Spectrum of Epidermolysis Bullosa in KwaZulu‐Natal, South Africa. International Journal of Dermatology, 64(8), 1425-1433. https://doi.org/10.1111/ijd.17843

Vancouver

Chateau A, Naicker T, Bruce-Brand C, Schneider J, Aldous C, Dlova N, et al. The Spectrum of Epidermolysis Bullosa in KwaZulu‐Natal, South Africa. International Journal of Dermatology. 2025;64(8):1425-1433. doi:10.1111/ijd.17843

BibTeX
@article{Chateau2025,
  author = {Chateau, Antoinette and Naicker, Thirona and Bruce-Brand, Cassandra and Schneider, Johann and Aldous, Colleen and Dlova, Ncoza and Cheng, Hui-Ching and Lin, Pei-Chi and Huang, Hsin-Yu and Hsu, Chao-Kai and McGrath, John A},
  title = {The Spectrum of Epidermolysis Bullosa in KwaZulu‐Natal, South Africa},
  journal = {International Journal of Dermatology},
  year = {2025},
  volume = {64},
  number = {8},
  pages = {1425--1433},
  doi = {10.1111/ijd.17843}
}
Kostenlos starten →